冯森玲，男，博士，副研究员，药学硕士研究生导师。博士毕业于澳门科技大学，2019年于广州医科大学附属第三医院工作。世界中联中医药免疫专业委员会理事、广东省药学会第二届药学科普专家委员会常务委员、广东省中医药学会中药药剂与药理专业委员会委员。国家自然科学基金及广东省自然科学基金评审，World Journal of Gastroenterology、Traditional Medicine Research、Frontiers in Pharmacology、山东医药等杂志编委及审稿专家。

联系邮箱:2019683088@gzhmu.edu.cn；slfengmust@163.com

研究方向:肿瘤耐药及药物抗肿瘤药理、动脉粥样硬化药理。

主要科研项目

1.国家自然科学基金-青年基金，82104446，主持

2.广东省自然科学基金面上项目，2023A1515011961，主持

3.广东省基础与应用基础区域联合基金，2019A1515111109，主持

4.广东省教育厅普通高校特色创新项目，2022KTSCX100，主持

5.广州市科技局市校（院）联合基础研究项目，SL2023A03J00851，主持

6.贺林院士新医学科研基金，2021HLKY02，主持

所获荣誉和奖励

1.2021年广州医科大学附属第三医院“毅文人才工程”计划

2.2020年澳门特别行政区科技研发奖

主要论文及著作

1.SL Feng1,HF Zhou1,DY Wu,DC Zheng,B Qu,RM Liu,C Zhang,Z Li,Y Xie*.HB Luo*. Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents[J].Acta Pharmaceutica Sinica B,2020,10(2):327-343.

2.SL Feng, HB Luo, L Cai, J Zhang, D Wang, YJ Chen, HX Zhan, Y Xie*.Ginsenoside Rg5 overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter: in vitro and in vivo study.J ginseng research.2020,44(2),247-257.

3.SL Feng1, Y Tian1, S Huo1, B Qu, RM Liu, P Xu,Y Xie*.Nobiletin potentiates paclitaxel anticancer efficacy in A549/T xenograft model: pharmacokinetic and pharmacological study[J].Phytomedicine,2020, 67.

4.SL Feng, ZW Yuan, XJ Yao, WZ Ma, L Liu & Y Xie*.Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.Pharmacological research. 2016;110:193-204.

5.Xie Ying1,Feng SenLing1, He Fang,Yan PeiYu,Yao XiaoJun,Fan XingXing, Leung Elaine Lai Han, Zhou Hua. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer[J]. Pharmacological research,2022,186.

6. Huang Hongliang, Dai Yuexiang, Duan Yingying,Yuan Zhongwen,Li Yanxuan, Zhang Maomao,Zhu Wenting,Yu Hang,Zhong Wenfei,Feng Senling*. Effective prediction of potential ferroptosis critical genes in clinical colorectal cancer [J]. Frontiers in Oncology,2022,12.

7.SL Feng1,YH Zhou1, HL Huang1, Y Lin, YF Zeng, SS Han, KK Huang, QZ Liu, WT Zhu, ZW Yuan*, BY Liang*. Nobiletin induces ferroptosis in human skin melanoma cells through the GSK3β-mediated Keap1/Nrf2/HO-1 signalling pathway.Frontiers in genetics.2022;13,865073:1-13.

8.Feng S1,Zhang J1, Liang B, Jin H, Yuan Z*. Effects of Cyclocarya paliurus flavonoid extract in non-alcoholic steatohepatitis mice: Intermeshing network pharmacology and in vivo pharmacological evaluation.Phcog Mag.2021;17: 765-773.

9.Feng SL1, Zhang J1, Jin H, Zhu WT, Yuan Z*. A Network Pharmacology Study of the Molecular Mechanisms of Hypericum japonicum in the Treatment of Cholestatic Hepatitis with Validation in an Alpha-Naphthylisothiocyanate (ANIT) Hepatotoxicity Rat Model.Med Sci Monit.2021,3;27:e928402.

【专利】

1.袁中文，冯森玲，严鹏科。一种治疗非酒精性脂肪肝的组合物及用途。No.202010464568。

2. Ma WZ,Feng SL, Yao XJ, Yuan ZW, Liu L, Xie Y. Use of tangeretin in cancer treatment. Australian Patent. No.2015101288. U.S. Patent No. 9,808,439.